Influence of European Market Dynamics on Biosimilars Market Share
Introduction: Innovative biologic medicines have been linked to a skyrocketing cost which introduces high pressures on the already constrained national health budgets. The adoption of biosimilars (similar versions of an approved biologic reference product) allows to expand patients' access to c...
Saved in:
Main Authors: | Diogo Pires (Author), João Gonçalves (Author) |
---|---|
Format: | Book |
Published: |
Formifarma, LDA.,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends
by: Elif Car, et al.
Published: (2023) -
Emerging Insights into European Markets of Biologics, Including Biosimilars
by: Steven Simoens, et al.
Published: (2022) -
Influência das dinâmicas dos mercados Europeus na market-share dos medicamentos Biossimilares
by: Diogo Amante Pires, et al.
Published: (2018) -
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
by: Evelien Moorkens, et al.
Published: (2020) -
Key drivers for market penetration of biosimilars in Europe
by: Cécile Rémuzat, et al.
Published: (2017)